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Abstract: The endoplasmic reticulum (ER) is a critical organelle, storing the majority of calcium
and governing protein translation. Thus, it is crucial to keep the homeostasis in all ER components
and machineries. The ER stress sensor pathways, including IRE1/sXBP1, PERK/EIf2α and ATF6,
orchestrate the major regulatory circuits to ensure ER homeostasis. The embryonic or postnatal
lethality that occurs upon genetic depletion of these sensors reveals the essential role of the ER stress
pathway in cell biology. In contrast, the impairment or excessive activation of ER stress has been
reported to cause or aggravate several diseases such as atherosclerosis, diabetes, NAFDL/NASH,
obesity and cancer. Being part of innate immunity, myeloid cells are the first immune cells entering
the inflammation site. Upon entry into a metabolically stressed disease environment, activation of
ER stress occurs within the myeloid compartment, leading to the modulation of their phenotype
and functions. In this review, we discuss causes and consequences of ER stress activation in the
myeloid compartment with a special focus on the crosstalk between ER, innate signaling and
metabolic environments.
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1. Introduction
1.1. The Endoplasmic Reticulum and its Stress Sensors
The endoplasmic reticulum (ER) is characterized by a peculiar structure whose shape and
architecture dictate the biological functions that occurs within this organelle. The ER is composed of a
complex system of membranes that gives rise to the NE (nuclear envelope) and peripheral ER, which is
composed of sheets and tubules [1]. The synthesis, folding and post-translational modification of
secreted and membrane proteins occurs within the sheet, also called rough ER, given the high density
of ribosomes loaded with mRNA. On the other side, tubules are smooth and highly curved and host
the calcium storage and lipid synthesis machinery. Interestingly, the ER structure is dynamic and can
quickly adapt in order to meet cellular demands in response to physiological or pathological stimuli.
Similarly, cells with different origins and functions also show diverse architectures of their ERs [2].
Pancreatic beta cells as well as B cells are characterized by enlarged sheet compartments, allowing large
production of secreted proteins; however, muscle cells and hepatocytes requiring calcium signaling for
contraction and lipid synthesis are distinguished rather by a prevalent tubular network [1].
As guardians of the ER, a three-branch system of proteins acts as a sensor of stress when quality
control does not match high standards. This system is known as unfolded protein response (UPR)
and undergoes activation upon accumulation of misfolded proteins or excess release of calcium
due to leakage of the membranes. The three branches are composed of protein kinase R (PKR)-like
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endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription
factor 6 (ATF6) [3]. Normally, all three sensors are kept in their inactive status by binding to the
chaperone BiP. BiP actively promotes protein folding, the import of polypeptides and the export
of misfolded protein towards the endoplasmic-reticulum-associated protein degradation (ERAD).
When misfolded proteins accumulate within the ER lumen, BiP dissociates from PERK, IRE1 and
ATF6 and leads to their activation. IRE1 and PERK can therefore switch from monomeric inactive
conformations to oligomers that allow autophosphorylation and activation. In addition, ATF6 is
cleaved to become an active form and enter the nucleus to promote the transcription of ER-stress
responder genes [4]. Interestingly, recent findings have described how PERK and IRE1 can also act as
lipid sensors. In the context of an UPR-independent ER stress response, changes in the composition
and/or saturation of lipids within the ER membranes can be detected by both PERK and IRE1 through
their transmembrane domains [5]. This intriguing discovery has opened new field of investigation and
helps us to understand the dynamics of ER stress response in different scenarios.
In mice, genetic knockout of PERK, IRE1 and ATF6 revealed a non-redundant, rather specific role
of the three sensors in response not only to pathological but also to physiological ER stress. PERK KO
mice are viable but show growth defects associated with skeletal dysplasia, dysfunctional pancreas
and hyperglycemia [6]. Pancreatic-specific KO could recapitulate the effect of the global KO, leading
to reduced beta cell proliferation, defects in insulin secretion and neonatal diabetes [7]. Given the
extraordinary secretory capacity of muscle and pancreatic cells, physiological ER stress occurs during
development and explain the phenotype observed in vivo. PERK has a dichotomous role, being able
to discern the severity of ER stress and promote growth arrest to allow repair or apoptosis when
ER stress is overwhelming. EIf2a is the main target of PERK. Once activated, EIf2a blocks protein
synthesis, allowing the cells to resolve the excess of misfolding and restore ER homeostasis. However,
in response to prolonged ER stress, PERK/EIf2α induces cell death through the transcription factor
CHOP [8,9]. Differently from PERK, IRE1 is not only a kinase but holds the unique ability to promote
IRE1-dependent decay (RIDD) of mRNA in order to release a stressed ER from the burden of newcomer
proteins [10,11]. In addition to that, IRE1 induces unconventional splicing of its main substrate XBP1
through its RNase domain. Spliced XBP1 mRNA encodes a functional transcription factor that mediates
the induction of folding machinery and lipid synthesis genes, both required for a proper ER stress
response [12]. Indeed, when dealing with overwhelming protein misfolding, the ER demands high
fatty acid and cholesterol generation in order to enlarge its membrane compartment [13]. KO mice of
IRE1 and XBP1 are both embryonically lethal [14,15]. However, while the XBP1 KO could be rescued
by liver-specific expression of the XBP1 transgene [16], this did not occur in IRE1 KO mice when
re-expressing IRE1 in liver [17]. Interestingly, embryonic lethality of IRE1 KO mice, which occurred
between day 9 and 11 during development due to vascular defects, was recovered by the expression of
endogenous IRE1 in the placenta, beautifully highlighting the importance of physiological ER stress in
the extraembryonic tissues and the blood vessel formation in the embryo [17]. These data also suggest
that XBP1 and IRE1 play functions that are dissimilar and independent of each other. Finally, ATF6 KO
mice also displayed very early embryonic lethality. However, the single knockout mice of the two
isoforms, ATF6α and ATF6β, were viable and fertile, suggesting a certain degree of redundancy during
embryonic development [18].
The diversity of phenotypes observed upon genetic depletion of IRE1/XBP1, PERK and ATF6
disclose a tissue-specific role but also highlight the possibility that the interaction network of the
three branches play an important role to differently activate these pathways upon various stimuli and
in different microenvironments. For example, it has been recently shown that in glucose deprived
conditions, PERK activates SCAF1 to promote the formation of respiratory supercomplexes within the
mitochondria in order to allow alterative energenetic machinery [19]. In contrast, CD4 T cells exposed
to low glucose in the tumor microenvironment undergo IRE1/XBP1-mediated ER stress, which reduces
mitochondrial respiration by limiting the expression of glutamine carriers on the membrane and
therefore blunting glutamine oxidation [20]. These apparently opposite findings suggest that the
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different ER stress sensor could have a very diverse function in response to similar stimuli, but also
highlight the possibility that pathological and physiological environments might preferentially activate
one or the other. In this context, it is well known that the ER stress response regulates onset,
progression and severity of a variety of pathologies such as cancer, diabetes, atherosclerosis, obesity
and neurodegenerative disease, extensively reviewed elsewhere [21,22]. These pathologies have in
common some key features, such as infiltration of innate immune cells and metabolic stress. Here we
discuss how ER stress is linked to innate immune cells and how metabolism can influence or perturb
this balance.
1.2. ER Stress and Immune Signaling
Part of the interaction network of ER stress responses contains components of immune signaling
pathways, such as STATs, JNK and NFκB. Upon activation, oligomeric IRE1 binds the scaffold
protein TRAF2, which is a main component of TNF-receptor signaling [15]. TRAF2 is able to
promote TAK1-dependent activation of IKKβ that favors the release of NFκB from its inhibitor
IκB [23,24]. In addition to that, TRAF2 is also responsible for ASK1-dependent activation of JNK [25].
PERK can also indirectly induce NFκB through EIf2α. By inhibiting the protein synthesis of IKβ,
PERK/EIf2α promote nuclear translocation of NFκB [26]. Both NFκB and JNK are known modulators
of inflammation, by promoting the expression of genes and the activity of proteins involved in the
regulation of inflammatory response [27]. Among the plethora of cytokines released by the UPR-derived
inflammation, IL-6 has been found to be regulated at different levels. In human melanoma cells, spliced
XBP1 induces IL-6 expression by directly binding IL-6 promoter. In turn, IL-6 further promotes STAT3
phosphorylation and boosts the pro-oncogenic effect of STAT3 [28]. The link between STAT3 and ER
stress has been further strengthened by other evidence. In murine hepatocytes, IRE1 binds and activates
STAT3 phosphorylation to foster tissue repair in response to liver damage [29]. Others have shown
that in astrocytes, PERK can directly bind JAK1 and promote STAT3 phosphorylation with following
increase of IL-6, CCL2 and CCL20 [30]. In the physiological context, the release of proinflammatory
cytokines through these pathways functions as damage signals and contributes to the maintenance
of tissue homeostasis through induction of cell death when ER stress is overwhelming and cannot
be resolved. Interestingly, it has been recently proven that IRE1/XBP1 signaling in myeloid cells can
increase pain perception by positively regulating the expression of prostaglandins and eicosanoids [31].
Once again, within a healthy organism this response represents an alert that helps resolution of
infection. However, in the pathological context, UPR-dependent activation of prostaglandins or other
inflammatory cytokines can rather boost the progression of disease and worsen its outcome.
2. ER Stress Response in Myeloid Cells
Myeloid cells are composed of mononuclear and polymorphonuclear cells and, together, take part
in innate immunity, representing the essential first line of defense against bacteria, parasites, viruses or
endogenous damage. Polymorphonuclear (PMN) cells or granulocytes include neutrophils, eosinophils
and basophils/mast cells, while mononuclear cells include macrophages and dendritic cells [32].
PMN cells are characterized by the exceptional presence of granules containing cytotoxic molecules
and inflammatory mediators that are specifically secreted upon stimulation by pathogens or other
damage [33]. As other secretory cells, PMNs require an extended ER in order to cope with an overload of
protein synthesis. On the other side, mononuclear cells are professional antigen-presenting cells (APCs),
which also require a perfectly functioning ER to allow antigen processing and presentation [34–36].
In the following paragraphs, we review the most recent literature that provides solid evidence of
ER stress involvement in the maturation, activation, functions and/or dysfunctions of myeloid cells in
different contexts.
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2.1. Macrophages
ER-stressed macrophages promote, reinforce, swap and in some cases ameliorate disease outcomes.
One of the reasons behind the overwhelming presence of ER stress response in macrophages is that
both pattern-recognition receptors, Toll-like receptor (TLRs) and nucleotide-binding oligomerization
domain-like NOD1 and NOD2 receptors, directly engage IRE1 activation to fully execute a resolutive
pro-inflammatory response [37,38]. ER stress inhibitors during Brucella abortis infection limit abortion of
disease by restraining IL-6 production in an IRE1- and NOD1/NOD2-dependent manner [37]. Similarly,
TLR2- and TLR4-dependent splicing of XBP1 occurs upon acute infection with Francisella tularensis
and essentially contribute to bacteria clearance by directly promoting the production of IL-6 and
TNFα [38]. In addition, IRE1 activation in macrophages also promotes inflammasome activation
that is essential to foster IL-1b production and to clear bacterial infection [39]. These pioneering
discoveries opened the road to a large number of studies that further confirmed the involvement
of IRE1/XBP1 in the pathophysiology of macrophage function during acute infection. Many more
studies have been then performed in the chronic setting and revealed that persistent ER stress
might instead be deleterious, rather than protective, for the progression of diseases. In a model
of chronic inflammatory arthritis, myeloid-specific ablation of IRE1 protected the mice from the
disease, attenuating the release of pro-inflammatory cytokines [40]. Interestingly, in the same study,
the authors mechanistically uncovered that TLR4 promotes TRAF6-dependent ubiquitination of IRE1
that impedes the binding of the phosphatase PP2a, therefore favoring IRE1 phosphorylation [40].
In other chronic diseases, such as obesity and atherosclerosis, ER-stressed macrophages contribute
to onset and progression of disease [41,42]. More specifically, it has been shown that in high-fat diet
(HFD)-induced obesity, IRE1-depleted macrophages alleviate pathological symptoms by favoring the
switch of pro-inflammatory macrophages towards anti-inflammatory [43]. In support of these findings,
in a genetic model of HFD-induced NASH (nonalcoholic steatohepatitis) and HCC (hepatocellular
carcinoma), treatment with ER stress alleviators PBA and TUDCA, improved disease outcomes by
limiting the release of TNF by inflammatory macrophages [44]. TUDCA and 4-PBA are chemical
chaperones that work by lowering the burden of unfolded protein within the ER [45]; 4-PBA has also
been successfully employed in the treatment of atherosclerosis in mice. In the atherosclerotic plaques,
lipid-laden macrophages undergo changes in lipid composition that induce ER stress and engage
PERK/CHOP-mediated apoptosis; 4-PBA was able to relieve macrophages from PERK activation,
prevent apoptosis and preserve their functions [46]. Accordingly, in a similar model of atherosclerosis,
treatment with the IRE1 inhibitors STF083010 or 4µ8c decreased plaque area by reducing macrophage
infiltration by limiting IL-1β and the recruiting chemokine CCL2 [47].
Both atherosclerosis and obesity are mainly characterized by a lipid-enriched microenvironment,
and macrophages tend to uptake these metabolites acquiring the status of “foam cell”. Therefore,
in these cells, beside UPR or in combination with it, ER stress sensors are mainly activated by changes
in the lipid composition and/or saturation of the membranes. It has been recently demonstrated
that in adipose-tissue macrophages isolated from obese mice, macrophage-specific depletion of
phosphocholine cytidylyltransferase A by limiting the turnover of PC favors the integration of
polyunsaturated fatty acid within the ER membrane, therefore reducing ER stress and retaining
inflammation [48]. In cancer, tumor-associated macrophages (TAMs) engage the IRE1-dependent
ER stress response upon synergistic action of IL-4, IL-6 and IL-10 that promotes cathepsin secretion
and increased pro-metastatic phenotype [49]. Interestingly, in this paper the authors found that
IL-6/IL-10-dependent STAT3 phosphorylation is upstream of IRE1 activation, adding other level of
complexity to the reciprocal regulation of IRE1/STAT3. Beside pro-tumoral macrophage, MDSCs
(myeloid-derived suppressive cells) have been recently described as cells expressing both macrophages
and granulocyte markers that contribute to the establishment of an immunosuppressive tumor
microenvironment, therefore blunting the anti-tumoral immune response [50]. In these cells,
tumor-derived stress factors drive CHOP activation in a PERK-dependent manner. By boosting IL6
production, CHOP favors the instauration of an immunosuppressive microenvironment. MDSC-specific
Cells 2020, 9, 695 5 of 11
deletion of CHOP synergizes with immune checkpoint blockade inhibitors to cure lung, melanoma,
thymoma and colon tumors [51]. These findings extensively prove that ER stress is actively involved in
pathophysiological mechanisms, having a protective role in acute macrophage response and adverse
effects in chronic disease (Figure 1). However, these studies have also opened new fields of investigation
that aim to clarify when and how the switch occurs and, most importantly, how the ER stress players
are specifically activated in different contexts.
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microenvironment, which promotes unfolded protein response (UPR) activation. In addition to that, 
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composition of the ER membrane. UPR and lipid accumulation trigger an excessive IRE1/PERK-
mediated ER stress response that results in chronic release of pro-inflammatory mediators and 
induction of cell death that contributes to the progression of disease. 
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Dendritic cells (DCs) represent the connection arm between innate and adaptive immunity. DCs 
are able to cross-present antigens to CD8+ and CD4+ T cells, unleashing their activation and the 
engagement of antigen-specific immune responses. Based on location and functions, many subsets of 
DCs exist, varying from professional antigen-presenting cells to inflammatory DCs. Features and 
differences of DCs subsets have been nicely reviewed elsewhere [52]. As other innate cells, DCs have 
myeloid origin and are activated by DAMPs and PAMPs through the expression of PRRs receptors. 
Once activated, antigen-loaded DCs migrate to draining lymph nodes where they encounter naïve T 
cells. Binding of the MHC/antigen complex to the T cell receptor in T cells leads to their activation 
and migration to the site of infection. The molecular mechanism orchestrating the process of antigen 
presentation is complex and to some extent still not completely uncovered [53]. The ER host the 
loading of antigens on MHCI or MHCII complexes and for this reason many reports have 
demonstrated that the ER guardians are indirectly involved in the antigen processing and 
presentation [54]. In one of the first papers showing the connection between ER stress and DCs, it 
was drastically proven that XBP1 deletion in the hematopoietic compartment impairs development 
and survival of dendritic cell lineage [55]. Immature DCs constitutively activate XBP1, which in turn 
regulates their differentiation in a cell intrinsic manner. However, the molecular mechanism behind 
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phenotype upon genetic loss of XBP1 is different in distinct subsets. Splenic dendritic cells show 
impaired antigen presentation associated with a disturbed ER architecture. IRE1/XBP1 signaling is 
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Figure 1. Engagement of ER stress responses in macrophages. Macrophage activation occurs through
Toll-like receptors (TLRs) upon binding with DAMPs (Damage-associated molecular patterns) and
PAMPs (Pathogen-associated olecular patterns). IRE1, as downstream target of TLRs, induces XBP1
splicing and inflammasome activation therefore promoting generation of pro-inflammatory cytokines.
This function of IRE1 is esse ial to keep homeostasis and t uccessfully resolve acute infections. On the
other hand, many chronic diseases are characterized by a metabolically altered microenvironment,
which promotes unfolded protein response (UPR) activation. In addition t that, activ ted macrophages
uptake lipids from the extracellular space, leading to change in the lipid composition of the ER
membrane. UPR and lipid accumulation trigger an excessive IRE1/PERK-mediated ER stress response
that results in chronic release of pro-inflammatory mediators and induction of cell death that contributes
to the progression of di eas .
2.2. Dendritic Cells
Dendritic cells (DCs) represent the connection arm between innate and adaptive immunity.
DCs are able to cross-present antigens to CD8+ and CD4+ T cells, unleashing their activation and the
engagement of antigen-specific immune resp nses. Based on location and functions, many subsets
of DCs exist, varying from professional antigen-presenting cells to inflammatory DCs. Features and
differences of DCs subs ts ave been nicely review d elsewhere [52]. As other innate cells, DCs have
myeloid origin and are activated by DAMPs and PAMPs through the expression of PRRs receptors.
Once activated, antigen-loaded DCs mi rate to draining lymph nodes where they encounter naïve T
cells. Binding of the MHC/antigen complex to the T cell receptor in T cells leads to their activation
and migration to the site of infection. The molecular mechanism orchestrating the process of antigen
presentation is complex and to some extent still not completely uncovered [53]. The ER host the loading
of antigens on MHCI or MHCII complexes and for this reason many reports have demonstrated that
the ER guardians are in irectly involved in the antigen pr ces ing nd prese tation [54]. In one of
the first papers showing the connection between ER stress and DCs, it was drastically proven that
XBP1 deletion in the hematopoietic compartment impairs development and survival of dendritic cell
lineage [55]. Immature DCs constitutively activate XBP1, which in turn regulates their differentiation
in a cell intrinsic manner. However, the molecular mechanism behind this crucial role of XBP1 was not
elucidated. Later, more studies clarified that the severity of the phenotype upon genetic loss of XBP1 is
different in distinct subsets. Splenic dendritic cells show impaired antigen presentation associated
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with a disturbed ER architecture. IRE1/XBP1 signaling is constitutively activated in splenic dendritic
cells and promotes cross-presentation by directly regulating the expression of proteins crucial for
the antigen loading into MHC complex [56]. In contrast, conditional knockout of XBP1 under the
CD11c promoter results in ablation of lung DCs via CHOP-mediated apoptosis. In the same mouse
model, mucosal DCs survived. However, upon pharmacological blockade of IRE1 activity (which is
overactivated in XBP1 KO), mucosal DCs also undergo cell death, suggesting a different threshold of
IRE1 activation in different tissues [57]. These studies have been performed in absence of infection and
therefore are limited to the physiological status of DCs. However, as it occurs for macrophages, upon
TLR activation, ER stress pathways are engaged in DCs and contribute to their function. Strikingly,
treatment of DCs with TLR4 and TLR8 agonists induces CHOP activation and its direct binding to
the promoter of the pro-inflammatory cytokine IL-23 [58] (Figure 2). Similarly, it has been recently
published that palmitic acid or HFD are able to reinforce the effect of TLR7/8 agonist IMQ by boosting
IL-23 production in DCs, upon activation of CHOP and sXBP1-mediated ER stress response [59].
In cancer, dendritic cells are loaded with lipid that undergo peroxidation and induce an XBP1-mediated
ER stress response. Conditional knockout mice harboring XBP1 deletion in dendritic cells were strongly
protected against tumor growth compared to WT mice. Mechanistically, XBP1 boosts triglyceride
production and further widens the overloading of lipids, therefore disturbing the machinery of antigen
presentation and blunting anti-tumor response [60]. In contrast, a study performed in human graft vs.
host disease (GVHD), has shown that DCs-specific sXBP1 deletion strongly suppress alloreactive CD4
T cells, and pharmacological block of spliced XBP1 protects against rejection. Moreover, the authors
provided evidence that this phenomenon is restrict to GVHD, because intratumoral T cell response
was not affected by XBP1-expressing DCs [61]. In conclusion, by directly or indirectly controlling
antigen presentation in combination with TLR signaling, ER stress acts as major hub in regulating DCs
functions and therefore represent an attracting therapeutic target. However, more studies are needed
in order to fully understand how duration and intensity of inflammation and priming are interplaying
with the ER guardians to balance physiologic versus pathologic DC responses.
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Figure 2. The ultifaceted roles of ER stress responses i myeloid cells. ER stress mediators play an
important role in modulating development and function of innate immune cells. Immature dendritic
cells (in light blue) require IRE1/XBP1 activation in order to differentiate in mature DCs. Mature DCs,
upon encounte ing DAMPs and PAMPs activate PERK/CHOP pathw y t accomplish a full activation
and the release of IL-23. In macrophages IRE1/XBP1 promotes activation of proinflammatory IL-6 and
TNF. However, i dis ase context, excessive activation of ER stress u on lipid a cumulation lead to
the formation of foam cells, cell death and impaired resolutive response. In neutrophils, activation
of ER stress is associated with increased cell death during development and upon tissue damage.
In the context of hyperinsulinemia, mast cells accumulate lipid bodies that cause ER stress response
IRE1/XBP1, which results in inhibition of degranulation. Eosinophil precursor (EoP) constitutively
activate XBP1 in order to give rise to mature eosinophils.
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2.3. Granulocytes
2.3.1. Neutrophils
In neutrophils, ER stress sensors have been shown to play an important role to control
degranulation process. Indeed, in an acute model of lung injury, activation of complement C5a
induces IRE1/XBP1-mediated ER stress, which in turn facilitates degranulation and progression of
disease. Neutrophil-specific ablation of XBP1 alleviates tissue injury by decreasing release of granules
and proinflammatory cytokines [62]. Others have shown that neutrophil formation requires membrane
integrity of the ER and the right ratio of phosphatidylcholine/phosphatidylethanolamine (PC/PE).
Genetic inducible knockout of FASN (fatty acid synthase) in bone marrow results in severe neutropenia
by specifically reducing the levels of PC within the endoplasmic reticulum of granulocytes, therefore
leading to CHOP-mediated ER stress response and massive neutrophil cell death [63]. Similarly, in a
model of angiotensin II-mediated cardiac injury, CHOP positively controls neutrophils apoptosis by
favoring the resolution of inflammation within the heart [64]. These data suggest that awaking ER stress
response during physiological turnover of neutrophils might profoundly affect their representation
within the bone marrow. However, upon inflammatory response, CHOP-mediated cell death in
neutrophils helps to degranulate and die in order to recruit macrophages to resolve inflammation.
2.3.2. Eosinophils
Eosinophils are at the frontline in the battle against parasites infection and allergies. As other
granulocytes, they develop from granulocyte macrophage progenitor (GMP) that give rise to eosinophil
progenitor (EoP) [65]. The main evidence that ER stress is involved in eosinophil biology come from
a report in which the authors used hematopoietic depletion of XBP1 in order to assess its role in
leucocytes development. Strikingly, in these mice eosinophil formation was completely impaired
and as compensation more neutrophils or mast cells were produced. The depletion of XBP1 causes
cell intrinsic defects by reducing protein folding ability of the cells and favoring the formation of
immature granule proteins that are essential for eosinophil formation [66]. As it occurs for other
secretory cells, this specific branch of ER stress is activated during development and its role is crucial
to keep homeostasis during hematopoiesis.
2.3.3. Basophils/Mast Cells
Basophils and mast cells have many common features but represent two different specific cell type
that together with eosinophils, are essential to sustain Th2-immunity in response to helminth infection
or allergies. It is technically challenging to work with these cells and for this reason, their functional
biology is not well known yet. For the same reason, only few studies have analyzed the role of ER
stress response in the pathophysiological function of these cells. In a model of hyperinsulinemia
caused by high fat diet, accumulation of lipid bodies in mast cells causes a reshuffling of lipid species
within the ER membrane. As consequence, ER stress response is initiated and, differently from what it
occurs in neutrophils, it inhibits degranulation [67]. Although the molecular link between ER stress
and degranulation has not been fully demonstrated, this report suggests that mast cell dysfunction in
insulin resistance might be attributed to ER stress.
3. Conclusions
Although extensive research has focused on understanding how ER and stress sensing orchestrate
the biology of innate immunity in response to physiological and pathological stimuli (Figure 2),
more effort is needed in order to clarify many aspects still unresolved. The role of ATF6 in all myeloid
compartments remains largely unexplored due to lack of efficient tools that allow for the proper
detection of the activation of this pathway [68]. More insights into ATF6 might help to fill in the
dark gaps in the puzzle of the ER stress role in innate immune cells. In addition to that, it became
recently clear that the three branches of ER guardians are not only activated by UPR but also by
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lipid overload and change in the composition of lipid-associated membranes. However, how these
changes are sensed is not completely understood yet. It is possible that the stiffness or other physical
features of the membranes favors the formation of oligomers and the activation of ER stress pathways.
Finally, pharmacological approaches targeting PERK and IRE1 pathways have been initiated and many
inhibitors have been employed in various disease contexts in preclinical mouse models or human
clinical trials [69]. However, some limitations are defined by the lack of knowledge on different aspects.
Genetic studies have highlighted how the block of one branch leads to overcompensation of the others.
Careful evaluation of compensatory mechanisms should be evaluated in all disease context. Moreover,
as described above, ER stress is necessary for development and physiological function of the innate
immune system. Therefore, evaluation of side effects upon exposure to infection or wounds should be
carried out in order to assess the risk/benefit balance upon ER stress-targeting therapies.
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